Details

Autor(en) / Beteiligte

• Lehmacher, Jonas
• Toprak, Betül
• Sörensen, Nils Arne
• Bei der Kellen, Ramona
• Goßling, Alina
• Hartikainen, Tau Sarra
• Haller, Paul Michael
• Schock, Alina
• Twerenbold, Raphael
• Zeller, Tanja
• Blankenberg, Stefan
• Westermann, Dirk
• Neumann, Johannes Tobias

Titel

Validation of a 0/1 h Algorithm for Rapid Diagnosis of Myocardial Infarction Using a High-Sensitivity Troponin I Assay

Ist Teil von

• Clinical chemistry (Baltimore, Md.), 2023-04, Vol.69 (5), p.482-491

Ort / Verlag

US: Oxford University Press

Erscheinungsjahr

2023

Quelle

Oxford Journals 2020 Medicine

Beschreibungen/Notizen

• Abstract Background Current guidelines recommend 0/1 h algorithms using high-sensitivity cardiac troponin (hs-cTn) for fast diagnosis of myocardial infarction (MI). Yet, for some assays, existing data is limited. We aimed to evaluate the diagnostic performance and the prognostic value of a rapid 0/1 h algorithm for the Access hs-cTnI assay. Methods In consecutive patients presenting with suspected MI, we measured concentrations of Access hs-cTnI at presentation and after 1 hour. Final diagnosis was adjudicated independently by 2 cardiologists. Parameters for diagnostic performance were calculated, applying the recently derived European Society of Cardiology (ESC) 0/1 h algorithm for Access hs-cTnI. Additionally, we assessed the prognostic utility of Access hs-cTnI for the composite end point of all-cause mortality and incident MI at 3 years. Results In 1879 patients, 257 non-ST-elevation MIs occurred. Application of the 0/1 h algorithm classified 44.5% as rule-out, 20.3% as rule-in, and triaged 35.1% to the observe group. High rule-out safety was confirmed with a sensitivity of 97.7% (95% CI, 95.0%–99.1%) and a negative predictive value of 99.3% (95% CI, 98.4%–99.7%). Rule-in capacity was moderate with a specificity of 88.0% (95% CI, 86.3%–89.6%) and a positive predictive value of 50.8% (95% CI, 45.7%–55.9%). After exclusion of patients with ST-elevation MI the results showed strong prognostic value, even after adjustment for cardiovascular risk factors and comorbidities, with adjusted hazard ratios of 2.51 (95% CI, 1.56–4.04) in the observe and 3.55 (95% CI, 2.18–5.79) in the rule-in group for the composite end point of all-cause mortality and incident MI at 3 years, compared to ruled-out patients. Conclusion The ESC 0/1 h algorithm for Access hs-cTnI allows safe and efficient triage of patients with suspected MI and has strong prognostic utility up to 3 years after the initial evaluation.